Inventor · disambiguated record
Dimitri Krainc
Also filed as: KRAINC DIMITRI
14 granted patents·2 pending applications·52 citations·filing 2003–2020
90Inventor score
Files withUNIV NORTHWESTERN11GEN HOSPITAL CORP2BIAL R&D INVEST S A1KRAINC DIMITRI1LYSOSOMAL THERAPEUTICS INC1
Top patents by PatentIndex Score
16 records- 0196US10751341B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersLYSOSOMAL THERAPEUTICS INC·Filed 2019·Granted Aug 25, 2020·12 cites·35 claims
- 0294US11351173B2Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disordersBIAL—R&D INVEST S A·Filed 2020·Granted Jun 7, 2022·3 cites·19 claims
- 0394US10040799B2Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2017·Granted Aug 7, 2018·8 cites·4 claims
- 0494US9802942B2Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2016·Granted Oct 31, 2017·11 cites·12 claims
- 0593US10227352B2Substituted 4-methyl-pyrrolo[1,2-A]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2018·Granted Mar 12, 2019·6 cites·12 claims
- 0692US10442812B2Substituted 4-methyl-pyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2019·Granted Oct 15, 2019·7 cites·20 claims
- 0781US10167270B2Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2016·Granted Jan 1, 2019·3 cites·10 claims
- 0874US10501435B2Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2018·Granted Dec 10, 2019·1 cites·20 claims
- 0974US2020010474A1Substituted 4-methyl-pyrrolo[1,2-a]pyrimidine-8-carboxamide compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2019·Application pending·0 cites
- 1067US10934270B2Substituted quinazoline compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2019·Granted Mar 2, 2021·0 cites·20 claims
- 1160US9284366B2Anti-acetylated huntingtin antibodies and uses therofKRAINC DIMITRI·Filed 2007·Granted Mar 15, 2016·1 cites·7 claims
- 1257US10882865B2Pyrrolopyrimidine compounds and uses thereof for modulating glucocerebrosidase activityUNIV NORTHWESTERN·Filed 2019·Granted Jan 5, 2021·0 cites·19 claims
- 1351US7045306B2Method for identifying compounds in vitro that modulate the dysregulation of transcription of transcription mediated by mutant huntingtin proteinGEN HOSPITAL CORP·Filed 2003·Granted May 16, 2006·0 cites·3 claims
- 1450US2007015183A1Biomarkers for huntington's diseaseGEN HOSPITAL CORP·Filed 2006·Application pending·0 cites
- 1548US12291533B2Substituted fused pyrimidine compounds and uses thereofUNIV NORTHWESTERN·Filed 2018·Granted May 6, 2025·0 cites·7 claims
- 1644US10286038B2Lysosome membrane protein 2 (LIMP-2) based peptides and related usesUNIV NORTHWESTERN·Filed 2017·Granted May 14, 2019·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →